These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26208944)

  • 1. Glioblastoma multiforme in the very elderly.
    Connon FV; Rosenthal MA; Drummond K
    Neurosurg Rev; 2016 Jan; 39(1):55-60; discussion 60-1. PubMed ID: 26208944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
    Scoccianti S; Magrini SM; Ricardi U; Detti B; Buglione M; Sotti G; Krengli M; Maluta S; Parisi S; Bertoni F; Mantovani C; Tombolini V; De Renzis C; Lioce M; Fatigante L; Fusco V; Muto P; Berti F; Rubino G; Cipressi S; Fariselli L; Lupattelli M; Santoni R; Pirtoli L; Biti G
    Neurosurgery; 2010 Aug; 67(2):446-58. PubMed ID: 20644432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment.
    Pessina F; Navarria P; Cozzi L; Rudà R; Nibali MC; Simonelli M; Costa F; Santoro A; Clerici E; Carta G; Scorsetti M; Bello L
    Acta Neurochir (Wien); 2018 Sep; 160(9):1779-1787. PubMed ID: 29971562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.
    Oszvald A; Güresir E; Setzer M; Vatter H; Senft C; Seifert V; Franz K
    J Neurosurg; 2012 Feb; 116(2):357-64. PubMed ID: 21942727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience.
    Straube C; Scherb H; Gempt J; Bette S; Zimmer C; Schmidt-Graf F; Schlegel J; Meyer B; Combs SE
    Radiat Oncol; 2017 Apr; 12(1):77. PubMed ID: 28454549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
    Hoffermann M; Bruckmann L; Kariem Mahdy A; Asslaber M; Payer F; von Campe G
    Clin Neurol Neurosurg; 2015 Jan; 128():60-9. PubMed ID: 25462098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre.
    Gauden AJ; Hunn A; Erasmus A; Waites P; Dubey A; Gauden SJ
    J Clin Neurosci; 2009 Sep; 16(9):1174-9. PubMed ID: 19540125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and treatment patterns of glioblastoma in the elderly: a population-based study.
    Gulati S; Jakola AS; Johannesen TB; Solheim O
    World Neurosurg; 2012 Nov; 78(5):518-26. PubMed ID: 22381305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma--the consequences of advanced patient age on treatment and survival.
    Stark AM; Hedderich J; Held-Feindt J; Mehdorn HM
    Neurosurg Rev; 2007 Jan; 30(1):56-61; discussion 61-2. PubMed ID: 17119901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and survival study in high-grade glioma in the elderly.
    Álvarez de Eulate-Beramendi S; Álvarez-Vega MA; Balbin M; Sanchez-Pitiot A; Vallina-Alvarez A; Martino-González J
    Br J Neurosurg; 2016 Jun; 30(3):330-6. PubMed ID: 26828095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
    Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
    World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.